sponsor/cro responsibilities-gcp workshop 27 feb 2017
TRANSCRIPT
GCP Workshop: Sponsor/CRO Responsibilities
Hanaa Abdel-Maguid
TCD MENA © 2017 1
TCD MENA © 2017 2TCD MENA © 2017 2
GCP Definition
Sponsor/CRO Responsibilities
Regulatory Affairs
Project Management
Clinical Operations
Biometrics
Medical Writing
Pharmacovigilance
Quality Assurance
Contents
TCD MENA © 2017 3
GCP Definition
TCD MENA © 2017 4TCD MENA © 2017 4
Definition
A person or an organization (commercial, academic, or other)
contracted by the sponsor to perform one or more of a sponsor's trial-
related duties and functions. ICH-GCP E6 (R2) § 1.2
CRO Responsibilities:
Implement systems and procedures for conduct of and assessment
of safety in clinical trials
Conduct CTs in accordance with the applicable regulations and
guidelines
Abide by contract signed with the sponsor
Communicate concerns to the sponsor in a timely manner
Maintain accurate records
Contract Research Organization (CRO)
TCD MENA © 2017 55
Pharmacovigilance& Safety Reporting
Medical & Biometrics Services
RegulatoryAffairs
CRO Responsibilities
TCD MENA © 2017
Project Management & ClinOps
TCD MENA © 2017 6TCD MENA © 2017 6
Regulatory Affairs
TCD MENA © 2017 7TCD MENA © 2017 7
Clinical trials should be conducted in accordance with the ethical
principles that have their origin in the Declaration of Helsinki, and that
are consistent with GCP and the applicable regulatory requirement(s).
(ICH GCP E6(R2) § 2.1
The role of RA department is to ensure compliance (in relation to
trials) Adherence to all the trial-related requirements, Good Clinical
Practice requirements, and the applicable regulatory requirements.
(ICH GCP E6(R2) § 1.15
This compliance is maintained by performing several activities in
Consequential manner.
Regulatory Authority
TCD MENA © 2017 8TCD MENA © 2017 8
Regulatory Affairs Activities
1- Receipt of all Study Documents
2- Study Documents Country Adaptations
3- Translation & Verification (for any document handed to patients)
4- EC Submission & EC approval.
5- RA Submission & RA approval.
6- Concerned authorities submission and approval (in case of biological samples exportation).
7- Investigator Budget negotiation/ Contracts Execution
8- Import License submission & approval.
9- MOH Clearance Authorization submission & approval.
10-IMP delivery to sites & Site initiation.
TCD MENA © 2017 9TCD MENA © 2017 9
Project Management
TCD MENA © 2017 10TCD MENA © 2017 10
Vendor Management and Qualification
Translation
Laboratories
Radiology
Drug Depot
Contracting (Sponsor, investigator, Vendor)
A written, dated, and signed agreement between two or more involved parties
that sets out any arrangements on delegation and distribution of tasks and
obligations and, if appropriate, on financial matters. The protocol may serve as
the basis of a contract. ICH-GCP E6 (R2) § 1.17
Clinical Project Management
TCD MENA © 2017 11TCD MENA © 2017 11
Project Oversight:
Ensure the interim and final project deliverables meet the sponsor’s
time, quality, and cost expectations;
Provide leadership, co-ordination and management of the project
team through start up, conduct, tracking, quality and regulatory
compliance and close-out activities;
Complete and monitor actual hours and expenses versus budget
Review and approve costs and ensure timely invoicing.
Clinical Project Management
TCD MENA © 2017 12TCD MENA © 2017 12
Monitoring Plan
Communication Plan
Risk Management Plan
Safety Plan
CRF completion guidelines
Data Management Plan
Clinical Project Plans
TCD MENA © 2017 13TCD MENA © 2017 13
ClinicalOperations Management
TCD MENA © 2017 14TCD MENA © 2017 14
Clinical Ops. Activities
• Site Selection (FQ)
• Pre-Study Visit (PSVs)
Start Up
• Study Site Initiation
• Clinical Monitoring• Monitoring
Report
Study Conduct
• Close Out Visits
Study Closure
TCD MENA © 2017 15TCD MENA © 2017 15
Clinical Monitoring
Monitor's Responsibilities
The monitor(s) in accordance with the sponsor’s requirements should
ensure that the trial is conducted and documented properly by carrying
out the necessary activities when relevant and necessary to the trial
and the trial site: ICH-GCP E6 (R2) § 5.18.4
TCD MENA © 2017 16
IRB/IECAPPROVAL
OPINION
SUBJECTENROLLMENT
MONITORING VISITS
During the monitoring visits, the Monitor will verify:
COMPLIANCEwith GCP andPROTOCOL
IP DISPENSING&
ACCOUNTABILITY
ADVERSEEVENT
REPORTING
CRFCOMPLETION
vs SOURCEDOCUMENTS
S FT IU LD EY
STUDYINITIATION
that the Investigator maintains the essential documents (ICH/GCP § 5.18.4)
S FT IU LD EY
Clinical Monitoring
TCD MENA © 2017 17
TCD MENA © 2017 17
CRFCRF
CRF DRF
code breaking material
OTHER
MATERIALS INVESTIGATOR’s
FILE ARCHIVE
to ensure that :
all SAEs have been reported to the
Sponsor
all CRFs have been verified against
source documents
all queries have been resolved by the
Investigator
all unused drugshave been returned to
the Sopnsor for destruction, and all decoding envelopeshave been retrieved
all unusedmaterials
have been retrievedfrom the study site
all essential documents have been maintained by
the Investigator
all arrangements for archiving have been made
by the Investigator
CLOSURE VISIT TASKS
18TCD MENA © 2017
TCD MENA © 2017 1819
Biometrics & Medical Writing
TCD MENA © 2017
TCD MENA © 2017 19TCD MENA © 2017 19
Biometrics & Medical Writing Process
Protocol writing
CRF Design
Informed Consent
Development
Statistical Analysis Plan
Edit Checks Development
Database Design
Data Management
Plan
Data Validation Process
Query Management
Data Cleaning
Database Lock
Medical Coding
Statistical Analysis Report
Clinical Study Report
Manuscript
TCD MENA © 2017 20TCD MENA © 2017 20
Biometrics & Medical Writing
Informed Consent
A Process by which a subject voluntarily confirms his or her willingness
to participate in a particular trial, after having been informed of all
aspects of the trial that are relevant to the subject’s decision to
participate. Informed consent is documented by means of a written,
signed and dated informed consent form. ICH GCP E6(R2) § 1.28
TCD MENA © 2017 21TCD MENA © 2017 21
Medical Writing
Protocol
A clinical trial protocol is a document that describes the objective(s),
design, methodology, statistical considerations, and organization of a
trial. Detail on the background of and rationale for the trial is usually
included in the protocol, although this information could be provided in
other protocol referenced documents., use the term protocol to refer to
the protocol and protocol amendment(s). ICH GCP E6 (R2) §1.44
TCD MENA © 2017 22TCD MENA © 2017 22
Medical Writing
Clinical Study Reports (CSR)
A written description of a trial/study of any therapeutic, prophylactic, or
diagnostic agent conducted in human subjects, in which the clinical and
statistical description, presentations, and analyses are fully integrated
into a single report. ICH GCP E6 (R2) § 1.13
Manuscripts
A final document in the clinical trial that is written according to specific
guidelines for publication purpose.
TCD MENA © 2017 23TCD MENA © 2017 23
Biostatistics
Statistical Analysis Plan (SAP):
A document that contains a more technical and detailed elaboration of
the principal features of the analysis described in the protocol, and
includes detailed procedures for executing the statistical analysis of the
primary and secondary variables and other data.
Statistical Analysis Report (SAR)
A report that contains the statistical analysis of the primary and
secondary variables and other data according to the study protocol.
TCD MENA © 2017 24TCD MENA © 2017 24
Data Management
Case Report Form Design (CRF)
A printed, optical, or electronic document designed to record all of the
protocol required information to be reported to the sponsor on each trial
subject. ICH GCP E6 (R2) §1.11
Database Design
An electronic form designed according to the approved CRF for storing
data from a clinical trial in an organized format.
TCD MENA © 2017 25TCD MENA © 2017 25
Data Management
Data Management Plan Development
A document to facilitate forward planning of all data management activities,
provide technical information and act as a reference document for auditors
or retrospective retrieval of data.
Data Validation Process
A process to ensures that the data are complete, valid and consistent.
Query Management
A process of raising queries for incomplete, invalid of inconsistent data for
investigators resolutions and update the database accordingly.
TCD MENA © 2017 26TCD MENA © 2017 26
Data Management
Medical Coding
A process coding the Adverse events and concomitant medications
according to Medical dictionaries (MedDRA, WHO Drug)
Data Cleaning
A process that grants that all the data have been entered, queries have
been raised by the Data management and resolved by the investigator in
order to proceed with database lock and start the Statistical Analysis
process.
TCD MENA © 2017 27TCD MENA © 2017 27
PV/Safety Reporting
TCD MENA © 2017 28TCD MENA © 2017 28
Pharmacovigilance &Safety Monitoring
Safety Monitor is responsible for immediate and follow-up reporting of
any SAEs to sponsor/ RA according to the safety reporting timelines
The immediate reports should be followed promptly by details, written
reports.
The immediate and follow-up reports should identify subjects by unique
code numbers assigned to the trial subjects rather than by the subjects’
name, personal identification numbers, and/or addresses. ICH GCP E6
(R2) § 4.11
TCD MENA © 2017 29TCD MENA © 2017 29
Pharmacovigilance &Safety Monitoring
Adverse events and/or laboratory abnormalities identified in the protocol
as critical to safety evaluations should be reported to the sponsor
according to the reporting requirements and within the time periods
specified by the sponsor in the protocol.
For reported deaths, the investigator should supply the sponsor and the
IRB/EC with any additional requested information.
The investigator should also comply with the applicable regulatory
requirements related to the reporting of unexpected serious adverse
drug reactions to the regulatory authority(ies) and the IRB/EC
ICH GCP E6 (R2) § 4.11
TCD MENA © 2017 30
TCD MENA © 2017 31
Quality Assurance
• Staff Training
• Systems, procedures and working practices
• Compliance ICH GCP, SA GCP, FDA …etc.
• Internal project-specific and system audits
Internal Functions
• Contracted trial site, laboratory & other vendors
• QA/training services (e.g. site training, GCP training)
External Functions
THANK YOU
WWW.TCD-GLOBAL.COM
TCD MENA © 2017 32